You're using a free limited version of DrugPatentWatch: Upgrade for Complete Access

Last Updated: November 21, 2024

Olmesartan medoxomil - Generic Drug Details


✉ Email this page to a colleague

« Back to Dashboard


What are the generic sources for olmesartan medoxomil and what is the scope of freedom to operate?

Olmesartan medoxomil is the generic ingredient in two branded drugs marketed by Cosette, Accord Hlthcare, Alembic, Alkem Labs Ltd, Amneal, Aurobindo Pharma, Chartwell Rx, Glenmark Pharms Ltd, Inventia, Jubilant Generics, Lupin Ltd, Macleods Pharms Ltd, Micro Labs, MSN, Prinston Inc, Qilu, Rising, Sandoz, Sciegen Pharms Inc, Sunshine, Teva Pharms Usa, Torrent, Umedica, and Zydus Pharms, and is included in twenty-four NDAs. Additional information is available in the individual branded drug profile pages.

There are thirty-six drug master file entries for olmesartan medoxomil. Twenty-nine suppliers are listed for this compound.

Drug Prices for olmesartan medoxomil

See drug prices for olmesartan medoxomil

Recent Clinical Trials for olmesartan medoxomil

Identify potential brand extensions & 505(b)(2) entrants

SponsorPhase
EMSPhase 3
Seoul National University Bundang HospitalPhase 4
Shenzhen People's HospitalPhase 2

See all olmesartan medoxomil clinical trials

Pharmacology for olmesartan medoxomil
Medical Subject Heading (MeSH) Categories for olmesartan medoxomil
Paragraph IV (Patent) Challenges for OLMESARTAN MEDOXOMIL
Tradename Dosage Ingredient Strength NDA ANDAs Submitted Submissiondate
BENICAR Tablets olmesartan medoxomil 5 mg, 20 mg and 40 mg 021286 1 2006-04-25

US Patents and Regulatory Information for olmesartan medoxomil

Applicant Tradename Generic Name Dosage NDA Approval Date TE Type RLD RS Patent No. Patent Expiration Product Substance Delist Req. Exclusivity Expiration
Alkem Labs Ltd OLMESARTAN MEDOXOMIL olmesartan medoxomil TABLET;ORAL 206763-001 Apr 24, 2017 AB RX No No ⤷  Sign Up ⤷  Sign Up ⤷  Sign Up
Prinston Inc OLMESARTAN MEDOXOMIL olmesartan medoxomil TABLET;ORAL 206720-001 Dec 2, 2022 AB RX No No ⤷  Sign Up ⤷  Sign Up ⤷  Sign Up
Msn OLMESARTAN MEDOXOMIL olmesartan medoxomil TABLET;ORAL 217399-003 Jan 18, 2023 AB RX No No ⤷  Sign Up ⤷  Sign Up ⤷  Sign Up
Sandoz OLMESARTAN MEDOXOMIL olmesartan medoxomil TABLET;ORAL 090237-003 Apr 13, 2020 DISCN No No ⤷  Sign Up ⤷  Sign Up ⤷  Sign Up
Alembic OLMESARTAN MEDOXOMIL olmesartan medoxomil TABLET;ORAL 203012-003 Apr 24, 2017 AB RX No No ⤷  Sign Up ⤷  Sign Up ⤷  Sign Up
>Applicant >Tradename >Generic Name >Dosage >NDA >Approval Date >TE >Type >RLD >RS >Patent No. >Patent Expiration >Product >Substance >Delist Req. >Exclusivity Expiration

Expired US Patents for olmesartan medoxomil

Applicant Tradename Generic Name Dosage NDA Approval Date Patent No. Patent Expiration
Cosette BENICAR olmesartan medoxomil TABLET;ORAL 021286-001 Apr 25, 2002 ⤷  Sign Up ⤷  Sign Up
Cosette BENICAR olmesartan medoxomil TABLET;ORAL 021286-003 Apr 25, 2002 ⤷  Sign Up ⤷  Sign Up
Cosette BENICAR olmesartan medoxomil TABLET;ORAL 021286-004 Apr 25, 2002 ⤷  Sign Up ⤷  Sign Up
Cosette BENICAR olmesartan medoxomil TABLET;ORAL 021286-004 Apr 25, 2002 ⤷  Sign Up ⤷  Sign Up
Cosette BENICAR olmesartan medoxomil TABLET;ORAL 021286-003 Apr 25, 2002 ⤷  Sign Up ⤷  Sign Up
>Applicant >Tradename >Generic Name >Dosage >NDA >Approval Date >Patent No. >Patent Expiration

Make Better Decisions: Try a trial or see plans & pricing

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.